Improved influenza vaccines: full value vaccine assessment The Full Value of Improved Seasonal Influenza Vaccines Assessment (FVIVA) report outlines key considerations for advancing seasonal influenza vaccine development and describes the potential impact tha...

#Medsky🧪 @who.int released its flagship report, Improved Influenza Vaccines: Full Value Vaccine Assessment (FVIVA), a comprehensive analysis of the potential #publichealth, economic, & societal impact of next-generation #influenzavaccines

www.who.int/publications...

Maternal infections, rather than vaccines, are the primary concern for increased maternal inflammatory proteins leading to neurodevelopmental disorders in offspring, and current evidence suggests both #COVID19 and #influenzavaccines are not associated with an increased risk of these disorders.

New Vaccination Guidance for Adults With Heart Disease The American College of Cardiology (ACC) has published new immunization guidance for adults with cardiovascular disease. Synthesizing prior ACC and American Heart Association guidelines and evidence-b...

@jaccjournals.bsky.social ACC recommends immunisation against RSV, pneumonia & #COVID, as well as annual #influenzavaccines, for all patients with #cardiovasculardisease.
@jama.com

jamanetwork.com/journals/jam...

📢 Late Breaker Posters for #CoP2025 close tomorrow, 29 August!

Themes: mRNA & next-gen vaccines, mucosal/B/T cell immunity, assays, study designs, animal models, pandemic prep

🔗 buff.ly/wtu3hcZ

#InfluenzaVaccines #ISRV

📢 Late Breaker Posters for #CoP2025 open 15 August - close 29 August!

Submit your abstract

Themes: mRNA & next-gen vaccines, mucosal/B/T cell immunity, assays, study designs, animal models, pandemic prep

🔗 buff.ly/wtu3hcZ

#InfluenzaVaccines #ISRV

The CoP2025 program is coming together! Abstract notifications have gone out!

📍 Join us this October in Vienna for a key event in influenza vaccines.

🔗 Info + registration: buff.ly/8SVVZgd

#CoP2025 #InfluenzaVaccines #ISRV

#Medsky🧪 #IDSKY #immunosky #publichealth #Influenzavaccines could soon get some serious competition—or assistance. A new #clinicaltrial shows a single shot of a long-lasting flu drug may protect people for an entire season, and it might do so more effectively than vaccines.

and also to evaluate the approaches on developing NA-based influenza vaccines or enhancing immune responses against NA for current #influenzavaccines…
@tandfresearch.bsky.social

www.tandfonline.com/doi/full/10....

#Medsky🧪 #IDSky #immunosky #globalhealth #publichealth Interim 2024/25 #influenzavaccines effectiveness: 8 EU studies, Sep 2024-Jan 2025
www.eurosurveillance.org/content/10.2...

Global Influenza Vaccines Market to Hit US$ 13.7 Billion by 2032 Overview of the Influenza Vaccines Market The global influenza vaccines market plays a vital role in public health by providing critical protection again

Overview of the Influenza Vaccines Market


The global influenza vaccines market plays a vital role in public health by providing critical protection against seasonal and pandemic influenza. #influenzavaccines
a4marketresearch.com/global-influ...

Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United States During the 2023-2024 U.S. influenza season, vaccine effectiveness against influenza-associated hospitalizations and emergency department/urgent care encoun

#MedSky🧪 #IDsky #Immunosky #pedsky #publichealth #Influenzavaccines provided protection against influenza-associated illness across health care settings and age groups during the 2023-2024 influenza season.

academic.oup.com/cid/advance-...